Legend Biotech Corporatio...

NASDAQ: LEGN · Real-Time Price · USD
37.47
-0.24 (-0.64%)
At close: Aug 15, 2025, 3:59 PM
37.50
0.09%
After-hours: Aug 15, 2025, 06:06 PM EDT

Legend Biotech Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-158.13M -518.25M -445.72M -386.21M
Depreciation & Amortization
23.36M 20.45M 18.39M 13.92M
Stock-Based Compensation
68.94M 47.68M 34.34M 20.16M
Other Working Capital
-70.57M 53.04M 118.75M 114.42M
Other Non-Cash Items
-98.24M 128.19M 6.65M 187.74M
Deferred Income Tax
n/a n/a n/a -174.94M
Change in Working Capital
20.04M -71.34M 186.32M 140.87M
Operating Cash Flow
-144.03M -393.28M -200.03M -198.47M
Capital Expenditures
-14.11M -22.72M -22.27M -47.11M
Cash Acquisitions
n/a n/a n/a 3.21M
Purchase of Investments
-2.71B -4.86B -654.97M -377.96M
Sales Maturities Of Investments
1.93B 5.07B 613.61M 230.08M
Other Investing Acitivies
-54.34M -91.7M -14.71M -3.2M
Investing Cash Flow
-850.54M 92.79M -78.34M -194.98M
Debt Repayment
-4.02M -3.75M -2.6M -1.42M
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
n/a 211.56M 2.93M 4.64M
Financial Cash Flow
5.7M 791.49M 377.98M 626.66M
Net Cash Flow
-990.96M 491.68M 97.09M 233.25M
Free Cash Flow
-158.14M -416M -222.3M -245.58M